Atos

Atossa Therapeutics (ATOS) Advances Clinical Pipeline Amid Valua

GuruFocus · about 16 hours ago

Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update

PR Newswire · about 18 hours ago

Atos Amplify appoints Joost Paalvast as partner in Dutch business

Consultancy.eu · 3 days ago

Atos honored as Silver Stevie® award winner for Excellence in Agentic AI Deployment

Atos · 4 days ago

Agencies Push to Rethink ATOs as Continuous Risk Management

GovCIO Media & Research · 4 days ago

Atossa Therapeutics (ATOS) Shows Progress but Remains Priced for High Growth Despite Losses

GuruFocus · 9 days ago

Atossa Therapeutics (ATOS) Explores New Uses for (Z)-Endoxifen A

GuruFocus · 9 days ago

Atossa Therapeutics (ATOS) Focuses on Execution Amid Challenging Valuation and Mixed Guru Interest

GuruFocus · 9 days ago

Atos Group (AEXAF) (H1 2026) Earnings Call Highlights: Operating

GuruFocus · 9 days ago

Atos revenue drops in H1 despite UKI momentum

CRN UK · 9 days ago

Atos Group Reports Earnings Results for the Half Year Ended June 30, 2026

marketscreener.com · 9 days ago

Atos H1 2026 slides show margin gains, but shares sink 31% on growth

Investing.com · 9 days ago

Earnings call transcript: Atos Group H1 2026 revenue in line as shares sink 31%

Investing.com · 9 days ago

Atos Group posts strong H1 2026 results, on tra...

Pluang · 9 days ago

Atos Group (ATO.PA) latest press releases and corporate news

Yahoo Finance UK · 9 days ago

Availability of Atos Group’s 2026 Half-Year Financial Report

GlobeNewswire · 9 days ago

Availability of Atos Group’s 2026 Half-Year Financial Report

Yahoo Finance · 9 days ago

Atos Group H1 Revenue At Current Scope EUR 3.30 Billion

TradingView · 9 days ago

Availability of Atos Group’s 2026 Half-Year Financial Report

GlobeNewswire · 9 days ago

Atos Group - H1 2026 results - Strong first-half performance, building on sustained delivery. On track to achieve full-year targets.

Yahoo Finance · 10 days ago